In: Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2015, vol. 62, no. 7, p. 762-769
|
In: Heliyon, 2020, vol. 6, no. 5, p. e04025
The brain's major inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and the brain-derived neurotrophic factor (BDNF) play important roles in several stress- related disorders. Magnetic resonance spectroscopy (MRS) allows for non-invasive quantification of GABA concentration in the brain. We investigated the relationship between GABA concentration in the left dorsolateral prefrontal...
|
In: CNS Spectrums, 2020, vol. 25, no. 3, p. 445–447
In major depression, remission rate in response to monoaminergic antidepressant is around 50%. The lack of strong synergies between classical antidepressants and psychotherapy may be due to the molecular effects of classical antidepressants. They modulate synapses but they do not substantially influence synaptogenesis. They also increase brain-derived neurotrophic factor (BDNF). However, for...
|
In: CNS Neuroscience & Therapeutics, 2019, p. cns.13213
In spinal cord injured adult mammals, neutralizing the neurite growth inhibitor Nogo‐A with antibodies promotes axonal regeneration and functional recovery, although axonal regeneration is limited in length. Neurotrophic factors such as BDNF stimulate neurite outgrowth and protect axotomized neurons. Can the effects obtained by neutralizing Nogo‐A, inducing an environment favorable for...
|
In: International Journal of Legal Medicine, 2014, vol. 128, no. 1, p. 73-82
|
In: Psychopharmacology, 2014, vol. 231, no. 15, p. 2955-2965
|
In: Cancer Chemotherapy and Pharmacology, 2014, vol. 74, no. 6, p. 1307-1319
|
In: Intensive Care Medicine, 2006, vol. 32, no. 3, p. 439-444
|
In: Intensive Care Medicine, 2012, vol. 38, no. 12, p. 1990-1998
|
In: Acta Neurochirurgica, 2012, vol. 154, no. 8, p. 1337-1342
|